These effects were reversed after treatment with TRPM2 blockers FFA and 2-aminoethoxydiphenyl borate (2-APB), which confirmed the potential of TRPM2 blockade in the treatment of PD (Nazıroğlu et al., 2011). This evidence concerns the gene TRPM2 and Parkinson disease.